Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Samsung Electronics Denies Takeover Of Israeli Medical Device Maker OrSense

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Samsung Electronics denied a local newspaper report June 2 that it is seeking to buy Israeli medical device maker OrSense Ltd.

You may also be interested in...



Samsung Biologics Takes First Step In The CMO Business While Targeting Innovative Compounds By 2017

INCHEON, South Korea - Samsung Biologics entered the first stage of a plan to become a global biopharmaceutical company, breaking ground on a biologics manufacturing plant May 27. The company hopes to establish itself as a global contract manufacturer before entering the biosimilar sector with its first entrant, a biosimilar of the monoclonal antibody Rituxan (rituximab)

Financings In Brief

Device VC activity increases

Samsung Electronics Takes Over Leading Medical Device Maker Medison

SEOUL - South Korea's Samsung Electronics is further building its burgeoning presence in the healthcare sector through the takeover of the country's leading medical equipment maker Medison Co. from a private equity fund

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel